Oncologie
Primary efficacy analysis of a phase II study of neoadjuvant Bevacizumab, chemotherapy, and Trastuzumab in HER2-positive inflammatory breast cancer: BEVERLY 2 study
Lire la suite
Tout
Actualités RCTS
Publications
Success stories
Oncologie
Publication - 1 décembre 2011
Surgical post-opérative complications in neoadjuvant treatment including Bevacizumab for HER2-positive inflammatory breast cancer: results from a phase II prospective trial
Oncologie
Publication - 1 décembre 2011
Primary efficacy analysis of a phase II study of neoadjuvant bevacizumab (BEV), chemotherapy (CT) and trastuzumab (H) in HER2-positive inflammatory breast cancer (IBC): BEBERLY2 study
Oncologie
Publication - 1 décembre 2011
Complications post-opératoires dans le cadre d’un traitement néoadjuvant incluant le bevacizumab dans le cancer du sein inflammatoire (CSI) HER2 positif : résultats d’un essai prospectif de phase II
Rhumatologie
Publication - 1 décembre 2011
NSAID-intake according to the ASAS score in clinical trials evaluating TNF blockers:
Rhumatologie
Publication - 8 novembre 2011
Comparison of the validity of synovitis to predict structural damage in rheumatoid arthritis (RA) with regard to the joint examination modality (e.g. clinical versus ultrasonographic [US]). 
Rhumatologie
Publication - 8 décembre 2010
A randomised, multicentre, double-blind, placebocontrolled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial
Oncologie
Publication - 8 décembre 2010
Detection of HER2-positive circulating tumor cells and circulating endothelial cells in an ancillary study of the BEVERLY2 multicenter phase II trial of neoadjuvant chemotherapy combined with Trastuzumab and §Bevacizumab in HER2-overexpressing inflammatory breast cancer
Rhumatologie
Publication - 8 décembre 2010
Achievement of a patient acceptable symptom state (PASS) and of a minimum clinically important improvement (MCII) with etanercept in advanced ankylosing spondylitis: results of a double blind, placebo-controlled study (SPINE)
Rhumatologie
Publication - 8 décembre 2010
Nonsteroidal anti-inflammatory (NSAIDs) drug-sparing effect and sustained clinical improvement of etanercept in advanced and severe ankylosing spondylitis. Results of an open label extension following a randomized double blind placebo-controlled study (SPINE)